General information for adults, not personal medical advice. Regulatory discussion covers Japan and the United States; UK guidance is also cited for surgical risks. Updated 1 November 2026.
Some underweight patients may have enough fat for collection, but weight alone cannot establish that. A surgeon needs to assess a suitable donor site and your fitness for surgery against the planned collection. Even if fat can be collected, that does not guarantee enough usable cells after processing. Liposuction requires a medical assessment; CDC treats BMI as a screening measure, not a stand-alone decision about health. 002985.htmBmi categories
This question concerns collecting your own fat for a proposed cell-based procedure, not removing large amounts for body contouring. Collection, laboratory processing, and later administration are different steps. Ask for the risks and consent requirements of each, rather than treating the ability to collect fat as evidence that a treatment works. The treatment process includes those separate stages.
How Much Fat Is Enough?
The sources cited here do not establish a universal minimum collection volume or a harvest-success percentage for underweight patients. Ask the treating team for the amount required by its specific protocol, not a number borrowed from another clinic.
Fat volume is not the same as usable cell yield. In a University Hospital Regensburg laboratory study using human liposuction tissue, the isolation protocol and counting method changed the measured yield. This was a tissue-processing study, not a trial showing that underweight patients can safely provide a particular volume or benefit from treatment. PMC8148142
Ask which cells are intended, how the fat is processed, whether cells are used fresh or after culture, and what tests must pass before use. Request the collection target, planned number of administrations, and arrangements if the sample is insufficient or fails quality testing.
Why BMI Cannot Decide
For adults aged 20 and older, CDC defines underweight as BMI below 18.5 and healthy weight as 18.5 to below 25. BMI uses height and weight; it is a screening measure to consider alongside other findings. It does not identify a safe fat-collection site. Bmi categories
Local fat. Ask whether there is a suitable layer beneath the skin at the proposed site, rather than relying on total body weight.
Previous procedures. Tell the surgeon about prior liposuction, scars, or abdominal surgery that may affect site selection.
General health. Discuss recent weight loss, nutrition concerns, medical conditions, medicines, and previous anesthesia problems during the assessment.
What the Surgeon Needs to Check
A preoperative consultation includes a medical history and physical examination. Liposuction may use local or general anesthesia. 002985.htm For your proposed collection, ask the surgeon to explain the donor-site findings and how they relate to the requested volume. A pinch test is not a laboratory cell count or a guarantee that collection will succeed.
Pre-harvest check
Topic
What to clarify
What to request in writing
Donor site
Which areas were examined and considered suitable?
Selected site, collection target, and reasons to stop
Medical history
How do medicines, prior surgery, weight loss, or existing conditions affect the plan?
Any further assessment needed before proceeding
Anesthesia
Which method, monitoring, and recovery arrangements are proposed?
Responsible clinician and aftercare contact
Sample quality
What happens if too little tissue or too few usable cells are obtained?
Testing requirements, alternatives, and fee arrangements
Bring a medication list and previous surgery or anesthesia records. If comparing clinics, use the same written questions about staffing, processing, and follow-up; these are also covered in choosing a hospital in Japan.
A Consultation Scenario
Suppose one clinic says it needs “a small amount” and another gives a volume. Those answers are not yet comparable. Ask whether the figure refers to collected fluid and fat together, separated fat tissue, or the final cell preparation. Then ask what happens if the target is missed. This is a comparison exercise, not a reported patient case; an examination and the clinic’s laboratory requirements are still needed.
When Your Fat Falls Short
If no suitable collection plan can be agreed, you do not have to proceed or accept an immediate substitute. If bone marrow or donor cells are proposed, request a separate explanation of the product, collection or administration method, evidence for your condition, risks, and consent. The distinction between your own cells and donor cells matters; a change of cell source is not simply a solution to a volume problem.
Blood-forming stem-cell transplantation is used for certain cancers and other blood disorders, but it is a different treatment from a proposed fat-derived cell injection. Its established uses do not validate that injection or a substitute product. Stem cell transplant
Harvest Risks for Slim Patients
Small-volume collection still involves incisions and anesthesia. Liposuction can cause bruising, swelling, pain, numbness, scarring, fluid collections, infection, or uneven contour. Some swelling can last months, and contour or sensation changes may persist. These general liposuction recovery descriptions are not an individual timetable for cell harvest. 002985.htmLiposuction Ask how the proposed collection affects your remaining fat layer and contour; the fat-collection risks include donor-site issues as well as recovery concerns.
Serious complications include blood clots, fat embolism, organ injury, anesthesia complications, and death. 002985.htm Processing and later administration require their own risk assessment. FDA reports harms from unapproved regenerative products including infections, immune reactions, tumor formation, blindness, and neurological events. These reports concern different products and administration routes; they are not a complication rate for your proposed harvest or injection. Important patient and consumer information about regenerative medicine therapies
Study Numbers in Context
Both studies below cover general cosmetic liposuction, not small-volume harvest in Japan, and provide no personal percentage for an underweight patient.
A 2024 meta-analysis included 39 studies and 29,368 patients, with a mean BMI of 26.36. Its pooled contour-deformity estimate was 2.35% (95% confidence interval 1.05% to 5.16%). That population was not specifically underweight; the interval describes uncertainty in the pooled estimate, not your personal risk. 38563572
A U.S. study of reports from accredited outpatient facilities used an estimated 246,119 liposuction procedures during 2019–2021 as its denominator. The authors reported the following rounded rates: PMC10860384
U.S. outpatient study rates
Outcome
Rate
Count
Detailed confirmed complications
0.40%
984 of 246,119
Including reports without details
0.63%
1,561 of 246,119
Venous thromboembolism
0.03%
77 of 246,119
Deaths
0.009%
21 of 246,119
The estimated denominator, missing report details, and limited follow-up can affect these rates. Do not combine them with the meta-analysis or use either study to calculate the chance that an underweight patient will provide enough fat. PMC10860384
Japan Checks for Your Case
In Japan, a regenerative-medicine treatment-plan filing under the Act on the Safety of Regenerative Medicine is different from product marketing approval under the pharmaceuticals and medical devices framework. MHLW describes treatment-plan procedures; PMDA separately explains the product framework and lists approved products. A filing is not product approval or proof that the proposed treatment works. Plan0003
Ask whether your proposed intervention is an approved product for your condition and route, a clinical study, or a clinic-provided procedure under a filed plan. Then ask for the evidence supporting that exact use. Being able to collect enough fat answers none of those regulatory or efficacy questions.
Questions About Your Fat
Before agreeing to collection, get answers to these questions:
Which donor site is suitable, and what collection target is proposed for me?
What exactly does that volume measure, and what cell-quality requirements must the preparation meet?
What happens to fees and next steps if collection stops or the laboratory cannot release the sample?
Who provides anesthesia, monitoring, aftercare, and urgent support if a problem occurs?
What evidence and regulatory status apply to the exact product, condition, and administration route?
Bottom Line
Being underweight does not settle whether you can provide enough fat. You need a donor-site assessment, a protocol-specific collection target, and a plan for an inadequate sample. A successful collection does not guarantee usable cells or an effective treatment. Keep those decisions separate before agreeing to surgery.
Unsure whether your frame leaves a workable harvest site?
Send your questions on donor sites, volume, anesthesia, and backup plans, and talk through what to confirm with your doctor.
Sources accessed 1 November 2026. The studies cited do not provide an underweight-specific harvest-success rate or establish a universal minimum fat volume.